Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paracrine agents affecting the dermal papilla (DP) constitute a diverse group of signaling molecules that regulate the development and cycling of hair follicles. The dermal papilla acts as the command center of the hair follicle, secreting factors such as Fibroblast Growth Factor-7 (FGF-7), Insulin-like Growth Factor-1 (IGF-1), and Vascular Endothelial Growth Factor (VEGF) to stimulate the proliferation and differentiation of surrounding matrix keratinocytes (PMID: 23315354, 11157493). Conversely, inhibitory agents like Transforming Growth Factor-beta (TGF-beta) and Dickkopf-1 (DKK-1) are involved in triggering the regression (catagen) phase of the hair cycle (PMID: 12535017). In conditions like androgenetic alopecia, dihydrotestosterone (DHT) alters this paracrine environment, leading to follicle miniaturization. Therapeutic interventions, such as Minoxidil, are thought to work partly by enhancing the expression of these growth-promoting paracrine agents, while Finasteride reduces the DHT-mediated suppression of these pathways (PMID: 15337202). Understanding these complex mesenchymal-epithelial interactions is crucial for developing targeted regenerative therapies for hair loss.
Modulation of the hair follicle cycle by stimulating the transition from the resting (telogen) phase to the growth (anagen) phase and prolonging anagen duration through the upregulation of growth-promoting factors and downregulation of inhibitory cytokines.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paracrine signaling molecules of the dermal papilla (DP paracrine factors).